合成路線圖解——原料藥廠家武漢東康源

合成路線圖解——原料藥廠家武漢東康源

ID:28459181

大?。?6.54 KB

頁(yè)數(shù):3頁(yè)

時(shí)間:2018-12-10

合成路線圖解——原料藥廠家武漢東康源_第1頁(yè)
合成路線圖解——原料藥廠家武漢東康源_第2頁(yè)
合成路線圖解——原料藥廠家武漢東康源_第3頁(yè)
資源描述:

《合成路線圖解——原料藥廠家武漢東康源》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在應(yīng)用文檔-天天文庫(kù)

1、藥物詳細(xì)合成路線NameAminoglutethimide;AG-1;Orimeten;CytadrenChemicalName3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedioneCAS125-84-8RelatedCASFormulaC13H16N2O2StructureFormulaWeight232.28467TelE-mail027-8130226718007166089MrYuanchem@whdky.comCompany武漢東康源科技有限公司Activity/MechanismAdrenocorticalDysf

2、unctionTherapy,BreastCancerTherapy,CushingsSyndrome,Agentsfor,ENDOCRINEDRUGS,OncolyticDrugs,ProstateCancerTherapy,Antiglucocorticoids,AromataseInhibitorsSyn.Route1Route1animprovedprocedureforthelarge-scalepreparationof(r)-aminoglutethimidehasbeenreported.nucleophilicsubstitutionof1-c

3、hloro-4-nitrobenzene(i)withmethylcyanoacetateaffordedthe(nitrophenyl)cyanoacetate(ii),whichwasalkylatedwithdiethylsulfateinthepresenceofet3n,yielding(iii).hydrolysisanddecarboxylationofthecyanoester(iii)bymeansofk2co3inaqueousmeohprovidedthearylbutyronitrile(iv).subsequentmichaeladdi

4、tionwithmethylacrylategaveadduct(v).thiswashydrolyzedtothecyanoacid(vi),whichwasfurtherresolvedwith(-)-cinchonidine,yieldingthedesired(r)-enantiomer(vii).acid-catalyzedcyclizationof(vii)inboilingtoluenegeneratedtheglutarimidederivative(viii).thenitrogroupof(viii)wasfinallyreducedtoth

5、etitleaminoderivativebyhydrogenationoverpd/c.ListofintermediatesNo.(4s,7r,8s,9s,16s)-8-hydroxy-5,5,7,9,13-pentamethyl-16-[(e)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4-[(triethylsilyl)oxy]oxa-13-cyclohexadecene-2,6-dione(i)1-methyl-2-oxo-1,2-dihydro-4-pyridinecarbaldehyde2-(2-

6、phenyl-1h-indol-3-yl)-1-ethanamine;2-(2-phenyl-1h-indol-3-yl)ethylamine(1as,8r,9as)-3-(acetoxy)-7-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]-8-(hydroxymethyl)-1-[(4-methylphenyl)sulfonyl]-1,1a,2,3,8,9a-hexahydro-9h-azireno[2,3-c][1]benzazocin-9-one(ii)(1as,8r,9as)-7-(benzyloxy)-5-[[(

7、benzyloxy)methoxy]methyl]-3-hydroxy-8-(hydroxymethyl)-1-[(4-methylphenyl)sulfonyl]-1,1a,2,3,8,9a-hexahydro-9h-azireno[2,3-c][1]benzazocin-9-one(iii)(8r,9s,10s,12s)-6-(benzyloxy)-4-[[(benzyloxy)methoxy]methyl]-8-(hydroxymethyl)-11-[(4-methylphenyl)sulfonyl]-14-oxa-1,11-diazatetracyclo

8、[7.4.1.0(2,7

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問(wèn)題,請(qǐng)放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶請(qǐng)聯(lián)系客服處理。